Addressing Reproducibility in Stem Cell and PRP Therapies.

Animals Biological Therapy / methods Guidelines as Topic Humans Platelet-Rich Plasma Reproducibility of Results Stem Cell Transplantation / methods
CONSORT EQUATOR biological therapies platelet-rich plasma reporting guidelines stem cell

Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
04 2019
Historique:
received: 18 09 2018
revised: 16 11 2018
accepted: 19 11 2018
pubmed: 24 12 2018
medline: 18 12 2019
entrez: 24 12 2018
Statut: ppublish

Résumé

Stem cell and platelet-rich plasma (PRP) therapies are promising breakthroughs in the treatment of multiple conditions. However, the lack of reproducibility due to inaccurate reporting of the protocols used to obtain these biologics can hinder their therapeutic progress. A reporting guideline for biological therapies is required to address this issue.

Identifiants

DOI: 10.1016/j.tibtech.2018.11.010 PMID: 30579716
pubmed: 30579716
pii: S0167-7799(18)30320-2
doi: 10.1016/j.tibtech.2018.11.010
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-344

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Eduardo Anitua (E)

Eduardo Anitua Foundation for Biomedical Research, Vitoria, Spain; BTI - Biotechnology Institute ImasD, Vitoria, Spain; University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain. Electronic address: eduardo@fundacioneduardoanitua.org.

Roberto Prado (R)

Eduardo Anitua Foundation for Biomedical Research, Vitoria, Spain; BTI - Biotechnology Institute ImasD, Vitoria, Spain; University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Thérapeutique › Biothérapie › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Sang › Plasma sanguin › Plasma riche en plaquettes › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Addressing Reproducibility in Stem Cell and...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Addressing Reproducibility in Stem Cell and...